Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia, a genetic disorder affecting up to 50% of adults, is caused by an excessive response to androgens leading to hair follicle shrinkage. Treatments include FDA-approved drugs, other therapies like low-dose oral minoxidil, and hair transplantation.

Intramuscular triamcinolone and pulse therapy with oral predonine are effective for alopecia areata with manageable side effects, but better relapse prevention is needed.

The secretome from mesenchymal stromal cells shows promise for improving facial nerve injury treatment.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Radiotherapy can cause rare changes in hair color, which should be discussed with patients.

Improve chin and perioral scars with surgery, resurfacing, and other therapies, tailored to each patient.

Microneedling combined with other treatments significantly improves hair growth in people with hair loss and is safe.

New treatments and management strategies for skin conditions like melanoma and Spitz naevi were discussed at the dermatologists' meeting.

Plant-based chemicals may help hair growth and prevent hair loss but need more research to compete with current treatments.

Microneedling is a promising, simple, and cost-effective treatment for hair loss that works well with other therapies.

The 2004 hair research meeting presented new findings on hair cell differentiation, genetic factors in hair loss, hair pigmentation, and potential targeted therapies.

The document says a skin condition called alopecia areata causes hair loss and stress, and is treated with strong skin creams, injections, or other therapies, but treatment success varies.

Decreasing MIG6 can increase the movement and invasiveness of MEK-inhibited mutant NRAS melanoma, particularly when stimulated by EGF.

Topical minoxidil improved hair loss in a patient when used consistently.

Oral minoxidil may improve hair loss in men and women, but has some side effects.

Injectable platelet-rich fibrin may stop hair loss from Discoid lupus erythematosus.

Higher PD-1 levels are linked to fewer immune cells in hair follicles in alopecia areata.

CGF therapy may help hair regrowth and improve scars in DLE patients.

Pediatric dermatologists have varied preferences for treating alopecia areata in children, with no standard FDA-approved treatments and some using JAK inhibitors despite risks.

Acitretin is effective for severe skin conditions but has significant side effects and requires careful monitoring.

Acitretin treats severe skin conditions but requires careful monitoring due to serious side effects.

The issue included new and updated reviews on various health interventions, with significant findings on weight loss, psychological therapies, cancer treatment, and more.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

New regenerative treatments for hair loss show promise but need more research for confirmation.

The US and EU lead in cell and gene therapy regulations with more approvals and clinical trials, while India is in early stages with fewer approvals and expedited processes.

Nanomaterials show promise in improving wound healing but require more research on their potential toxicity.

Cells from the lower part of hair follicles are a promising, less invasive option for immune system therapies.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Using 5-aminolevulinic acid photodynamic therapy for hair loss didn't increase hair growth but slightly reduced scalp oiliness, and it was safe with mild side effects.